National Cancer Registry

Definition	A cancer registry is defined as a location, be it an office or institution, where collection, storage, analysis and interpretation of data on cancer patients take place (Jenson et al, 1991).
Objectives	- To measure cancer incidence - To describe cancer by time, place, persons and disease - To provide a national database for further epidemiological research
Case definition	Target cases are: - Incident cases by year of diagnosis - Malignant tumors confirmed by histopathology and/or hematology findings - Cancers of all sites
Sources of data	Data are collected through two main channels: the capture system (passive reporting) and the recapture system (active reporting). 1) The capture system: The capture system is based on physician’s routine reporting of cancer cases. Physician’s complete and send forms: - Directly from their clinic; or - Indirectly through the MOPH Drug Dispensing Center (DDC), where anti-cancer drugs are distributed to eligible patients 2) The recapture system: The recapture system is based on gathering information directly from histopathological and hematological laboratories. Data are collected in various ways, using hard or soft copies, or using database file or individual laboratory results depending on laboratories resources. This process is active since the NCR personnel actually contact the sites to obtain the necessary data. The recapture system validates and complements the capture approach.
Medical coding	The coding of cancer primary sites and cancer morphology is done using International Classification of Diseases for Oncology, third edition (ICD-O-3). The code includes information on the topography (primary site), the histology, the behavior and the grade of the tumor. The structure is C##.# M####/##, where: - C##.# specifies the primary site - M#### specifies the histology - /## specifies the behavior and the grade of the tumor
Reporting form	NCR reporting form

ATC	Name	B/G	Ingredients	Form	Price
M03BB53	RELAXON	G	Paracetamol - 300mg, Chlorzoxazone - 250mg	Capsule	296,989 L.L
M03BC51	NORGESIC	B	Paracetamol - 450mg, Orphenadrine (citrate) - 35mg	Tablet	412,560 L.L
N02BG09	PENTHROX INHALER	B	Methoxyflurane -	Inhalation	21,080,096 L.L
M03BC51	MUSCEROL 2	G	Paracetamol - 450mg, Orphenadrine (citrate) - 35mg	Tablet, scored	177,899 L.L
R05CA12	PROSPAN ACUTE EFFERVESCENT COUGH TABLETS	B	Dried Ivy leaf extract - 65mg	Tablet, effervescent	479,752 L.L
M03BC51	MUSCEROL EXTRA	G	Caffeine - 15mg, Paracetamol - 450mg, Orphenadrine citrate - 35mg	Tablet, scored	267,489 L.L
C05BX51	DOXIPROCT	B	Calcium dobesilate - 4%, Lidocaine HCl - 2%	Ointment	610,104 L.L
M03BC51	MUSCEROL 3	G	Paracetamol - 450mg, Orphenadrine citrate - 35mg, Ibuprofen - 200mg	Tablet, film coated	593,850 L.L
S01XA20	LUBRI-TEARS	G	Carmellose sodium - 2mg	Drops solution	792,867 L.L
C05BX51	DOXIPROCT PLUS	B	Calcium dobesilate - 4%, Dexamethasone acetate - 0.0025%, Lidocaine HCl - 2%	Ointment	489,159 L.L
D11AF	VERRUMAL	B	Fluorouracil - 0.5g/100g, Salicylic acid - 10g/100g	Solution	529,474 L.L
M03BX	DORIXINA RELAX	B	Lysine clonixinate - 125mg, Cyclobenzaprine HCl - 5mg	Tablet, film coated	581,884 L.L
B02BD06	HAEMATE P	BioHuman	Von Willebrand Factor - 600IU, Blood Coagulation Factor VIII - 250IU	Injectable lyophilised powder for solution+diluent	13,364,733 L.L
B05D	PERITONEAL DIALYSIS SOLUTION WITH 4 1/4% DEXTROSE	G	Sodium lactate - 0.392g%, Calcium chloride, 2H2O - 0.0257g%, Magnesium chloride, 6H2O - 0.0153g%, Sodium chloride - 0.567g%, Dextrose, H2O - 4.25g%	Injectable solution	498,744 L.L
B02BD06	HAEMATE P	BioHuman	Von Willebrand Factor - 2400IU, Blood Coagulation Factor VIII - 1000IU	Injectable lyophilised powder for solution+diluent	46,995,888 L.L
B05D	PERITONEAL DIALYSIS SOLUTION WITH 1 1/2% DEXTROSE	G	Sodium lactate - 0.392g%, Calcium chloride, 2H2O - 0.0257g%, Magnesium chloride, 6H2O - 0.0153g%, Sodium chloride - 0.567g%, Dextrose, H2O - 1.5g%	Injectable solution	490,807 L.L
R05CA12	JOS-PAN	G	Dried Ivy leaf extract (Hederacoside C) - 75mg/100ml	Syrup	306,396 L.L
B02BD06	HAEMATE P	BioHuman	Von Willebrand Factor - 1200IU, Blood Coagulation Factor VIII - 500IU	Injectable lyophilised powder for solution+diluent	31,900,938 L.L
B05D	CAPD/DPCA 17Solution for peritoneal dialysis stay safe	G	Sodium chloride - 5.786g/l, Sodium-(S)-lactate - 3.925g/l, Calcium chloride 2H2O - 0.1838g/l, Magnesium chloride, 6H2O - 0.1017g/l, Anhydrous glucose - 15g/l, Fructose , - up to 0.75g/l	Injectable solution	573,603 L.L
N02CC04	MAXALT	B	Rizatriptan (benzoate) - 10mg	Tablet	439,436 L.L
S02AA30	TYOTOCIN	B	Hexylresorcinol - 0.1%, Antipyrine - 5%, Benzocaine - 1.25%, Tyrothricin - 0.05%	Drops solution	409,552 L.L
B02BD06	WILATE 500	BioHuman	Von Willebrand Factor - 500IU, Blood Coagulation Factor VIII - 500IU	Injectable powder for solution+diluent	32,399,164 L.L
B05D	CAPD/DPCA 19Solution for peritoneal dialysis stay safe	G	Sodium chloride - 5.786g/l, Sodium-(S)-lactate - 3.925g/l, Calcium chloride 2H2O - 0.1838g/l, Magnesium chloride, 6H2O - 0.1017g/l, Anhydrous glucose - 22.73g/l, Fructose , - up to 1.1g/l	Injectable solution	700,560 L.L
R05CA12	HEDERAL		Dried Ivy leaf extract - 37mg/5ml		309,084 L.L
S02AA30	OTOCOL	G	Chloramphenicol - 50mg/ml, Benzocaine - 50mg/ml	Drops	163,949 L.L
B02BD06	HAEMATE P	BioHuman	Von Willebrand Factor - 1200IU, Blood Coagulation Factor VIII - 500IU	Injectable lyophilised powder for solution+diluent	L.L
B05D	CAPD/DPCA 2Solution for peritoneal dialysis stay safe	G	Sodium chloride - 5.786g/l, Sodium-(S)-lactate - 3.925g/l, Calcium chloride 2H2O - 0.2573g/l, Magnesium chloride, 6H2O - 0.1017g/l, Anhydrous glucose - 15g/l, Glucose monohydrate - 16.5g/l	Injectable solution	669,968 L.L
C05CA53	DAFLON	B	Hesperidin - 50mg, Diosmin - 450mg	Tablet, film coated	627,574 L.L
R05CA12	HEDECTON COUGH	G	Ivy leaf soft extract - 40mg/5ml	Syrup	467,657 L.L
S02CA02	VIOCORTENE	B	Clioquinol - 10mg/ml, Flumetasone pivalate - 0.2mg/ml	Drops	568,253 L.L

National Cancer Registry (NCR)